The Role of Pulmonary Metastasectomy in Breast Cancer with Limited Progression Following CDK4/6 Inhibitor Therapy: A Case Report
Metastatic breast cancer is primarily managed with systemic therapy; however, the role of pulmonary metastasectomy (PM) in patients with pulmonary oligometastases remains uncertain. We present the case of a 56-year-old postmenopausal woman who developed lung and bone metastases 4 years after resecti...
Saved in:
Main Authors: | Yu-Ting Su, Shang-Hung Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Cancer Research and Practice |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-24-00025 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in prognostic factors and survival outcomes following pulmonary metastasectomy for head and neck cancers
by: Konstantinos Grapatsas, et al.
Published: (2024-12-01) -
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01) -
Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification
by: Youngkyung Jeon, et al.
Published: (2024-01-01) -
Association between cytokines and progression-free survival in ovarian cancer following CRS/HIPEC treatment
by: Chao-Yu Chen, et al.
Published: (2025-01-01) -
Development and Validation of an MRI‐Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients
by: Wen‐Qi Liu, et al.
Published: (2024-12-01)